<--- Back to Details
First PageDocument Content
Observation / International nongovernmental organizations / United States Agency for International Development / Independent media / State media / Internews / International Center for Journalists / Media ethics / Free Press / News media / Journalism / Freedom of the press
Date: 2014-07-08 11:34:22
Observation
International nongovernmental organizations
United States Agency for International Development
Independent media
State media
Internews
International Center for Journalists
Media ethics
Free Press
News media
Journalism
Freedom of the press

global issues Seeking Free & Responsible Media An Electronic Journal of the U.S. Department of State

Add to Reading List

Source URL: photos.state.gov

Download Document from Source Website

File Size: 256,91 KB

Share Document on Facebook

Similar Documents

Press Release September 27, 2012 CloudBroker Platform Now Usable for Free with Own Cloud Infrastructures  CloudBroker GmbH and the SCIentific gateway Based User Support (SCI-BUS) EU FP7

Press Release September 27, 2012 CloudBroker Platform Now Usable for Free with Own Cloud Infrastructures CloudBroker GmbH and the SCIentific gateway Based User Support (SCI-BUS) EU FP7

DocID: 1xTO4 - View Document

Microsoft Word - Press Release Free Residential Workshopsdoc

Microsoft Word - Press Release Free Residential Workshopsdoc

DocID: 1vr3B - View Document

Two Bits - The Cultural Significance of Free Software Christopher M. Kelty © 2008 Duke University Press Printed in the United States of America on acid-free paper ∞

Two Bits - The Cultural Significance of Free Software Christopher M. Kelty © 2008 Duke University Press Printed in the United States of America on acid-free paper ∞

DocID: 1voqD - View Document

Press Release Desire, love, identity: exploring LGBTQ histories 11 May- 15 October 2017 Room 69a, free

Press Release Desire, love, identity: exploring LGBTQ histories 11 May- 15 October 2017 Room 69a, free

DocID: 1vmJT - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C   New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document